What did the HOPE trial investigate about ramipril in adults at high cardiovascular risk with preserved ejection fraction? See the design via 2 Minute Medicine’s expert summary. 

2 Minute Medicine, The Classics Series, and The Classics in Medicine are owned by 2 Minute Medicine, Inc.

The HOPE Trial: Ramipril reduces cardiovascular events in high-risk patients with normal ejection fractions

2 Minute Medicine™

Volume 2: General Chronic Disease and Cardiology from 2MM™ The Classics In Medicine

The Classics in Medicine series by 2 Minute Medicine is back on MedShr Learning, with 14 bite-size modules covering landmark trials in General Chronic Disease and Cardiology. Each module is built on foundation of high-quality research, providing actionable and evidence-based knowledge essential to every physician and healthcare professional. 

In this volume, landmark trials on heart failure, the CHADS2 score and acute myocardial infarction. Each module is built on a foundation of high-quality research, so you’re gaining more than just information—you’re gaining actionable, evidence-based knowledge. 
With contributions from renowned medical faculty and practicing physicians at top institutions, this chapter is an indispensable tool for the practicing physician or trainee. Some landmark trials included in this chapter are the HOT trial: Diastolic blood pressure targets in hypertension; the REMATCH trial: Left ventricular assist devices reduce mortality in heart failure; and the ACTIVE trial: Dual antiplatelet therapy in atrial fibrillation.

The remaining chapters from the textbook edition are organized into Classics by Specialty and includes trials from the following fields: General Chronic Disease and Cardiology, Critical and Emergent Care, Endocrinology, Gastroenterology, Hematology and Oncology, Imaging, Infectious Disease, Nephrology, Neurology, Pediatrics, Psychiatry, Pulmonology, Surgery, and COVID-19. More coming soon! 


Dowaa Saleh

What did the CONSENSUS trial examine about enalapril in severe heart failure? This module draws on 2 Minute Medicine’s expert summary of its design and reported outcomes.

The CONSENSUS Trial: Enalapril reduces mortality in severe heart failure

How did the Val-HeFT trial study valsartan in chronic heart failure? Explore the approach and reported findings through 2 Minute Medicine’s expert summary. 

The Val-HeFT Trial: Valsartan reduces morbidity in chronic heart failure

What did the CAST trial report when examining anti-arrhythmic suppression of ventricular ectopy after myocardial infarction? Review the key findings with 2 Minute Medicine’s expert summary. 

The CAST Trial: Anti-arrhythmic agents increase risk of death in patients after myocardial infarction

The V-HeFT II Trial: Enalapril reduces mortality in heart failure when compared to hydralazine and isosorbide in the General Chronic Disease and Cardiology series from 2MM's The Classics In Medicine

The V-HeFT II Trial: Enalapril reduces mortality in heart failure when compared to hydralazine and isosorbide

The SOLVD Trial: Enalapril reduces mortality in heart failure with reduced ejection fraction in the General Chronic Disease and Cardiology series from 2MM's The Classics In Medicine

The SOLVD Trial: Enalapril reduces mortality in heart failure with reduced ejection fraction

How did the SAVE trial examine captopril use after myocardial infarction in patients with left-ventricular dysfunction? See the design via 2 Minute Medicine’s expert summary.

The SAVE Trial: Captopril reduces mortality after acute myocardial infarction

What did the CARE study evaluate regarding pravastatin in patients with prior MI and average cholesterol levels? Review findings with 2 Minute Medicine’s expert summary. 

The CARE Trial: Pravastatin reduces risk of coronary events 

The DIG Trial: Digoxin reduces hospitalization in patients with systolic heart failure in the General Chronic Disease and Cardiology series from 2MM's The Classics In Medicine

The DIG Trial: Digoxin reduces hospitalization in patients with systolic heart failure

How was metoprolol studied in the MERIT-HF trial among patients with symptomatic heart failure? Learn through 2 Minute Medicine’s expert summary.

The MERIT-HF Trial: Metoprolol reduces mortality in patients with symptomatic heart failure

What did the RALES trial examine about spironolactone in severe heart failure? Explore the details with 2 Minute Medicine’s expert summary.

The RALES Trial: Spironolactone reduces mortality in heart failure patients

The ATLAS Trial: Angiotensin converting enzyme inhibitor dosing in chronic heart failure in the General Chronic Disease and Cardiology series from 2MM's The Classics In Medicine

The ATLAS Trial: Angiotensin converting enzyme inhibitor dosing in chronic heart failure

The MIRACL Trial: Atorvastatin reduces recurrent ischemia after acute coronary syndrome in the General Chronic Disease and Cardiology series from 2MM's The Classics In Medicine

The MIRACL Trial: Atorvastatin reduces recurrent ischemia after acute coronary syndrome

The CHADS2 score Trial: Stroke risk in atrial fibrillation in the General Chronic Disease and Cardiology series from 2MM's The Classics In Medicine

The CHADS2 score Trial: Stroke risk in atrial fibrillation

The REMATCH Trial: Left ventricular assist devices reduce mortality in heart failure in the General Chronic Disease and Cardiology series from 2MM's The Classics In Medicine

The REMATCH Trial: Left ventricular assist devices reduce mortality in heart failure

The Classics in Medicine series by 2 Minute Medicine is back on MedShr Learning, with 14 bite-size modules covering landmark trials in General Chronic Disease and Cardiology. Each module is built on foundation of high-quality research, providing actionable and evidence-based knowledge essential to every physician and healthcare professional.&nbsp;In this volume, landmark trials on heart failure, the CHADS2 score and acute myocardial infarction.&nbsp;Each module is built on a foundation of high-quality research, so you’re gaining more than just information—you’re gaining actionable, evidence-based knowledge.